Status:
RECRUITING
Is MIO-RSA Noninferior to BIO-RSA When it Comes to Mechanical Implant Stability?
Lead Sponsor:
Lovisenberg Diakonale Hospital
Conditions:
Arthroplasty Complications
Shoulder Osteoarthritis
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
This clinical trial will investigate whether metallic lateralization in reverse shoulder arthroplasty is as stable as bony lateralization during the first two postsurgical years, measured with CT-base...
Detailed Description
Lateralization of reverse shoulder arthroplasties may reduce the risk for complications such as limited range of motion (ROM), and scapular notching, where the lower part of the scapular neck becomes ...
Eligibility Criteria
Inclusion
- Eligible for primary RSA due to OA, massive RC tear, failed RC repair or post-instability osteoarthritis
- massive glenoid medialization
- Able to read or write Norwegian
Exclusion
- Severe osteoporosis
- Osteonecrosis of the humeral head
- Dementia
- Poor deltoid function
- Revision surgery
- ASA IV
- Suspected chronic infection
- Acute fracture
Key Trial Info
Start Date :
October 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2033
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06025448
Start Date
October 30 2023
End Date
March 1 2033
Last Update
November 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lovisenberg Diaconal Hospital
Oslo, Norway, 0456